Dutch AI Startup Raises €2.3 Million to Predict Surgical Infections Before They Occur

2026-03-30 bio

Netherlands, Monday, 30 March 2026.
Netherlands-based Healthplus.ai secured €2.3 million in funding to expand PERISCOPE®, an artificial intelligence system that predicts post-operative infection risks for individual patients and provides targeted recommendations to healthcare teams. The technology can save hospitals up to €4 million annually by reducing costly complications and readmissions while integrating seamlessly with existing hospital systems like Epic and Oracle Cerner across European markets.

Healthtech Innovation Addresses Critical Healthcare Challenge

This development represents a significant advancement in healthtech, specifically targeting one of healthcare’s most pressing concerns: post-operative complications [1]. The funding round was led by Elevating Capital and LUMO Labs, with participation from Pathena Venture Capital, Leistone (Renza Family), and ROM InWest [1]. Healthplus.ai, founded by CEO and founder Dr. Bart Geerts, is based in Amsterdam and aims to drive healthcare transformation by reducing complications and alleviating pressure on medical staff through predictive analytics [1][6].

How PERISCOPE® Technology Works

PERISCOPE® operates by analyzing approximately 50 clinical parameters to predict the risk of post-operative infections for individual patients [4]. The system integrates directly with existing Electronic Health Record (EPD) systems including Epic, Oracle Cerner, and ChipSoft, which serve the Dutch and broader European markets [1][4]. The AI system automatically calibrates to work accurately across different types of hospitals while maintaining regulatory compliance [1]. According to Dr. Boris de Cort, a surgical resident at Deventer Ziekenhuis, “We’ve built clear clinical pathways around the risk scores. High-risk means closer monitoring and earlier labs. Low-risk means more confidence when discharging” [2].

Proven Clinical Impact and Financial Benefits

The technology has been validated across multiple surgical specialties in collaboration with leading academic medical centers [4]. Hospitals using PERISCOPE® report earlier identification of high-risk patients, enabling proactive care decisions and more efficient resource allocation [4]. The system also enables safer, more confident discharge planning through accurate identification of low-risk patients, all without adding extra documentation burden or disrupting existing workflows [4]. The financial impact is substantial, with the system potentially saving hospitals up to €4 million per year by reducing post-operative complications, which represent a major cost driver and source of workplace pressure [1].

Strategic Expansion Plans and Market Context

Healthplus.ai plans to use the €2.3 million investment to accelerate rollout across Europe and begin expansion into the United States market [1]. The company will also invest in further development of AI risk models for all phases surrounding surgical operations [1]. This funding comes at a strategic time for the Dutch MedTech sector, which according to industry analysis, is experiencing a transition toward industrial maturity in 2026 after structural recalibration in 2024 and tentative recovery in 2025 [5]. The company’s ambitious goal is to enable proactive surgical care for over 50 million patients annually by 2029 [6]. As Sara Schaafsma, Investment Manager at ROM InWest, noted: “Through accurate patient stratification, doctors and nurses can create much better treatment plans for patients, intervene faster with high-risk patients, and safely discharge low-risk patients home earlier” [1].

Bronnen

AI healthcare surgical prediction